Telesis Bio Total Assets 2021-2024 | TBIO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Telesis Bio total assets from 2021 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Telesis Bio total assets from 2021 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$141.6B
Bristol Myers Squibb (BMY)	$116.3B
Gilead Sciences (GILD)	$115.4B
Vertex Pharmaceuticals (VRTX)	$102.3B
CSL (CSLLY)	$83.8B
Regeneron Pharmaceuticals (REGN)	$77.1B
GSK (GSK)	$69.6B
Argenex SE (ARGX)	$37.7B
Alnylam Pharmaceuticals (ALNY)	$31.7B
BioNTech SE (BNTX)	$27.1B
Illumina (ILMN)	$21.6B
Biogen (BIIB)	$21.3B
BeiGene (BGNE)	$17.2B
Moderna (MRNA)	$15.2B
Genmab (GMAB)	$13.4B
Incyte (INCY)	$13.3B
Insmed (INSM)	$12.6B
BioMarin Pharmaceutical (BMRN)	$12.5B
Bio-Techne Corp (TECH)	$11.6B
Sarepta Therapeutics (SRPT)	$11.4B
Exact Sciences (EXAS)	$11B
Vaxcyte (PCVX)	$10.8B
QIAGEN (QGEN)	$10.2B
Swedish Orphan Biovitrum (BIOVF)	$10.2B
Exelixis (EXEL)	$9.5B
Bio-Rad Laboratories (BIO.B)	$9.1B
Intra-Cellular Therapies (ITCI)	$8.8B
Roivant Sciences (ROIV)	$8.4B
Ascendis Pharma (ASND)	$8.3B
Repligen (RGEN)	$8.1B